报告题目： Global Health Care: Advances and Challenges
报告人：Yasemin M. Akay, 美国休斯敦大学生物医学工程系教授
报告时间：2017年12月4日上午10:30
报告地点：二教南楼524（学院会议室）
报告人：Yasemin M. Akay, 美国休斯敦大学生物医学工程系教授
报告时间：2017年12月4日上午10:30
报告地点：二教南楼524（学院会议室）
报告内容：
The National Academy of Engineering announced the 14 Grand Challenges for Engineering at the annual meeting of the American Association for the Advancement of Science. The committee also praised biomedical and biological engineering as the research field to fulfill the promise of personalized medicine. Included among these 14 challenges were Reverse–Engineering the Brain, Engineer better Medicines and Advance Health Informatics.
The objectives of this presentation are to discuss the global health care systems, financing, delivery and management. We will also focus on the recent technological advances in health care and their use in diagnosing, treating, and preventing diseases, using novel technologies to develop new drugs, technology regulation, and ethical issues surrounding the use of novel technologies.
个人简介：
Yasemin M. Akay is currently an Assistant Professor at the Department of Biomedical Engineering, Cullen College of Engineering, University of Houston. She received her B.S. in Pharmaceutical Sciences from the Hacettepe University, Ankara, Turkey in 1980 and M.S. and Ph.D in Biomedical Engineering from the Rutgers University, Piscataway, NJ, USA in 1991 and 1998, respectively.
Her research focuses on novel technologies forcost-effective high-through put screening of novel cancer drugs and therapeutics and assessment of treatment responses.
She is currently exploring the effect of maternal smoking during pregnancy by analyzing the mRNA expressions of a single cell analysis of the infant rats’ dopamine neurons using patch-clamp electrophysiology and DNA microarrays.
The National Academy of Engineering announced the 14 Grand Challenges for Engineering at the annual meeting of the American Association for the Advancement of Science. The committee also praised biomedical and biological engineering as the research field to fulfill the promise of personalized medicine. Included among these 14 challenges were Reverse–Engineering the Brain, Engineer better Medicines and Advance Health Informatics.
The objectives of this presentation are to discuss the global health care systems, financing, delivery and management. We will also focus on the recent technological advances in health care and their use in diagnosing, treating, and preventing diseases, using novel technologies to develop new drugs, technology regulation, and ethical issues surrounding the use of novel technologies.
个人简介：
Yasemin M. Akay is currently an Assistant Professor at the Department of Biomedical Engineering, Cullen College of Engineering, University of Houston. She received her B.S. in Pharmaceutical Sciences from the Hacettepe University, Ankara, Turkey in 1980 and M.S. and Ph.D in Biomedical Engineering from the Rutgers University, Piscataway, NJ, USA in 1991 and 1998, respectively.
Her research focuses on novel technologies forcost-effective high-through put screening of novel cancer drugs and therapeutics and assessment of treatment responses.
She is currently exploring the effect of maternal smoking during pregnancy by analyzing the mRNA expressions of a single cell analysis of the infant rats’ dopamine neurons using patch-clamp electrophysiology and DNA microarrays.